Panneaux obligatoires selon ISO 7010, Protection du visage obligatoire, 200 mm, 1 pièce

Methyl 6-bromo-3-chloropicolinate, 98.0%, 1g

4-Boc-7-Methyl-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine, 97.0%, 250mg

Boc-Phe-ONp, 95.0%, 100g

H-Orn(N3).HCl, 98.0%, 250mg

5,6-Diaminopyrimidine-2,4-diol sulfate, 95.0%, 5g

5-Hydroxybenzo[de]isochromene-1,3-dione, 95.0%, 25g

Solution d'hydroxyde de sodium, ROTI® volume 0,1 mol/l - 0,1 N, ampoule, 1 pièce, emballage plastique.

4-[6-[[6-(1-Butoxyvinyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl]amino]pyridin-3-yl]piperazine-1-carboxylic acid tert-butyl ester, 98%, 250mg

4-bromo-2H-indazol-6-amine, 97%, 5g

(2,4-Dihydroxyphenyl)(4-hydroxyphenyl)methanone, 97%, 25g

methyl 3-iodo-2-methyl-2H-indazole-6-carboxylate, 98%, 1g

1-(5-Fluoropyridin-3-yl)ethan-1-ol, 95%, 2.5g